4//SEC Filing
Aimmune Therapeutics, Inc. 4
Accession 0000899243-17-002765
CIK 0001631650operating
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 6:47 PM ET
Size
4.9 KB
Accession
0000899243-17-002765
Insider Transaction Report
Form 4
Knapp Jeffrey H
Chief Operating Officer
Transactions
- Tax Payment
Common Stock, $0.0001 par value
2017-02-03$17.89/sh−2,224$39,787→ 2,776 total
Footnotes (1)
- [F1]The reported sale was made pursuant to a pre-determined election to sell shares to cover tax withholding obligations in connection with the vesting of a previously reported equity award.
Documents
Issuer
Aimmune Therapeutics, Inc.
CIK 0001631650
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001631650
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 6:47 PM ET
- Size
- 4.9 KB